InsidersTradesSigma
Explore the detailed record of transactions filed by Broidrick Amy S., Président/Directeur Scientifique. Insider active across 1 company, notably Qualigen Therapeutics, Inc.. Aggregated, 1 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €18k. History available since 14 June 2022. The latest transaction was disclosed on 14 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Amy S. Broidrick is the President and Chief Scientific Officer at Qualigen Therapeutics, Inc. She is responsible for the scientific and strategic leadership of the company, overseeing research and development initiatives. Her expertise in the pharmaceutical field is essential in guiding innovation and growth.